Upadacitinib Monotherapy in Vitiligo Associated with Atopic Dermatitis: Killing Two Birds with One Stone
The remission of both AD and vitiligo achieved with upadacitinib monotherapy supports the therapeutic utility of inhibition of JAK 1 signaling in these patients.
Authors
- Maria Esposito (ORCID: https://orcid.org/0000-0002-4773-6993)
- Lina Maria Magnanimi (ORCID: https://orcid.org/0000-0003-2056-9483)
- Andrea De Berardinis (ORCID: https://orcid.org/0009-0008-6388-1438)
- Maria Concetta Fargnoli
Institutions
- University of L'Aquila (IT)
Publication Details
- Journal
- Case Reports in Dermatology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1159/000544703
- Citations
- 4
- Primary Topic
- melanin and skin pigmentation
- Type
- article
- Field-Weighted Citation Impact
- 4.61